Comprehension of complex biological processes by analytical methods: how far can we go using mass spectrometry?
Creators
Description
Comprehensive understanding of complex biological processes is the basis for many biomedical issues of great relevance for modern society including risk assessment, drug development, quality control of industrial products and many more. Screening methods provide means for investigating biological samples without research hypothesis. However, the first boom of analytical screening efforts has passed and we again need to ask whether and how to apply screening methods. Mass spectrometry is a modern tool with unrivalled analytical capacities. This applies to all relevant characteristics of analytical methods such as specificity, sensitivity, accuracy, multiplicity and diversity of applications. Indeed, mass spectrometry qualifies to deal with complexity. Chronic inflammation is a common feature of almost all relevant diseases challenging our modern society; these diseases are apparently highly diverse and include arteriosclerosis, cancer, back pain, neurodegenerative diseases, depression and other. The complexity of mechanisms regulating chronic inflammation is the reason for the practical challenge to deal with it. The presentation shall give an overview of capabilities and limitations of the application of this analytical tool to solve critical questions with great relevance for our society. (author)
Availability note (English)
Available in abstract form only, full text entered in this recordAdditional details
Publishing Information
- Imprint Title
- VERA Seminar
- Imprint Pagination
- [vp.]
- Journal Page Range
- [vp.]
Conference
- Title
- VERA Seminar
- Dates
- 10 Jan - 5 Dec 2013
- Place
- Vienna (Austria)
INIS
- Country of Publication
- Austria
- Country of Input or Organization
- Austria
- INIS RN
- 45076685
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Conference, Non-conventional Literature
- Descriptors DEI
- ARTERIOSCLEROSIS; DRUGS; INFLAMMATION; MASS SPECTROSCOPY; NEOPLASMS; NERVOUS SYSTEM DISEASES; RISK ASSESSMENT
- Descriptors DEC
- CARDIOVASCULAR DISEASES; DISEASES; PATHOLOGICAL CHANGES; SPECTROSCOPY; SYMPTOMS; VASCULAR DISEASES